Broach Lifecare Hospital Share Price
15.50+0.00 (+0.00%)
-38.98% past 1 Year
Broach Lifecare Hospital operates boutique hospitals under the brand name 'Maple Hospitals. It takes immense pride in being at the forefront of healthcare, with a dedicated focus on cardiac ailments.
Corporate filings & documents
Announcements
Broach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair. 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair.
3 days agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair. 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair.
3 days agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair.
3 days agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair.
3 days agoPlease find the attached intimation regarding resignation of company secretary and compliance office and disclosure under Regulation-30 of SEBI (LODR) Regulation 2015
3 days agoPlease find the attached intimation regarding resignation of company secretary and compliance office and disclosure under Regulation-30 of SEBI (LODR) Regulation 2015
3 days agoWe wish to inform you that the Board of Directors has appointed M/s. Rahul S. Mithaiwala & Co. as Secretarial Auditor of the Company for FY 2025-26.
1 week agoWe wish to inform you that the Board of Directors has appointed M/s. Rahul S. Mithaiwala & Co. as Secretarial Auditor of the Company for FY 2025-26.
1 week agoWe are enclosing herewith Outcome of Board Meeting held on August 26 2026.
1 week agoWe are enclosing herewith Outcome of Board Meeting held on August 26 2026.
1 week agoWe hereby inform you that the Company has received resignation letter dated August 24 2026 from Ms. Urvi Mrunal Hindia from the position of CFO of the Company.
1 week agoWe hereby inform you that the Company has received resignation letter dated August 24 2026 from Ms. Urvi Mrunal Hindia from the position of CFO of the Company.
1 week agoWe are enclosing herewith disclosure relating to the resignation of Secretarial Auditor M/s. N R Shah & Co. Secretarial Auditor of the Company w.e.f August 13 2026.
1 week agoWe are enclosing herewith disclosure relating to the resignation of Secretarial Auditor M/s. N R Shah & Co. Secretarial Auditor of the Company w.e.f August 13 2026.
1 week agoPlease find attached herewith the certificate under Reg 74(5) for the Quarter ended June 30 2026.
1 week agoPlease find attached herewith the certificate under Reg 74(5) for the Quarter ended June 30 2026.
1 week agoThe Company has received Permanent Certificate for Registration of Clinical Establishment from concerned authority for its Hospital at Bharuch.Consequent to the aforesaid approval the bed capacity of the Bharuch Hospital has increased from 25 beds to 50 beds. Accordingly overall bed capacity of Company has increased from 40 beds to 65 beds.
3 months agoThe Company has received Permanent Certificate for Registration of Clinical Establishment from concerned authority for its Hospital at Bharuch.Consequent to the aforesaid approval the bed capacity of the Bharuch Hospital has increased from 25 beds to 50 beds. Accordingly overall bed capacity of Company has increased from 40 beds to 65 beds.
3 months agoThe Company has received permanent Certificate for Registration of Clinical Establishment from Government of Gujarat Health and Family Welfare Department for 50 bed Capacity at Hospital located at Bharuch Gujarat
3 months agoThe Company has received permanent Certificate for Registration of Clinical Establishment from Government of Gujarat Health and Family Welfare Department for 50 bed Capacity at Hospital located at Bharuch Gujarat
3 months agoPursuant to Reg 30 of SEBI(LODR) Regulations 2015 we hereby submit duly signed audited standalone financial results for the half year and financial year ended on March 31 2026 along with Auditors report under reg. 33 of SEBI (LODR) Regulations 2015.
3 months agoStatement of Deviations and variations of funds raised through public issue (IPO) under Reg 32(1) if SEBI (LODR) Regulations 2015 as on March 31 2026 pursuant to allotment of equity shares on public issue (IPO).
3 months agoStatement of Deviations and variations of funds raised through public issue (IPO) under Reg 32(1) if SEBI (LODR) Regulations 2015 as on March 31 2026 pursuant to allotment of equity shares on public issue (IPO).
3 months agoAudited Standalone Financial Results of the company for the half year and year ended on March 31 2026 along with Auditors Report under Reg 33 of SEBI (LODR) Regulations 2015.
3 months agoAudited Standalone Financial Results of the company for the half year and year ended on March 31 2026 along with Auditors Report under Reg 33 of SEBI (LODR) Regulations 2015.
3 months agoWe hereby inform that Board of Directors of company at its meeting held today i.e. May 21 2026 inter alia have considered approved and taken on record inter-alia the following businesses:1. Audited Standalone Financial Results of the Company for the Half Year and Year ended March 31 2026 in terms of Regulation 33 of the Listing Obligations;2. Considered and approved other business matters as per the Agenda including any Other Business matters with the approval of the Chairman.A copy of the Audited Standalone Financial Results of the Company for the Half-Year and Year ended March 31 2026 along with the Auditors Report declaration with respect to the Audit Report with unmodified opinion on the Audited Standalone Financial Results Statement of deviation(s) and variation(s) Certificate of Correctness of financial results have been enclosed herewith. Kindly note that the meeting of the Board of Directors of the Company commenced at 04.00 p.m. and concluded at 06.15 pm.
3 months agoWe hereby inform that Board of Directors of company at its meeting held today i.e. May 21 2026 inter alia have considered approved and taken on record inter-alia the following businesses:1. Audited Standalone Financial Results of the Company for the Half Year and Year ended March 31 2026 in terms of Regulation 33 of the Listing Obligations;2. Considered and approved other business matters as per the Agenda including any Other Business matters with the approval of the Chairman.A copy of the Audited Standalone Financial Results of the Company for the Half-Year and Year ended March 31 2026 along with the Auditors Report declaration with respect to the Audit Report with unmodified opinion on the Audited Standalone Financial Results Statement of deviation(s) and variation(s) Certificate of Correctness of financial results have been enclosed herewith. Kindly note that the meeting of the Board of Directors of the Company commenced at 04.00 p.m. and concluded at 06.15 pm.
3 months agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve the meeting of the Board of Directors of BROACH LIFECARE HOSPITAL LIMITED (the Company) is scheduled to be held on Thursday May 21 2026 at 04.00 p.m. at the registered office situated at 501 5TH FLOOR CORPORATE HOUSE ABOVE BHARUCH ORTHOPAEDIC HOSPITAL R K CASTA BHARUCH-392001 GUJARAT INDIA to inter alia transact following business:1. To receive consider and approve the audited financial results for the half year and year ended on 31st March 2026 2. Other Business Agenda3. Any other business with permission of ChairpersonAs intimated to you vide letter dated March 28 2026 the trading window for dealing in shares of the Company by the designated persons is already closed since April 01 2026 until 48 hours of the declaration of financial results for the half year and year ended on March 31 2026.
3 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Broach Lifecare Hospital Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L86100GJ2023PLC140499</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SWATI SHARMA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: URVI MRUNAL HINDIA <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Broach Lifecare Hospital Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L86100GJ2023PLC140499</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SWATI SHARMA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: URVI MRUNAL HINDIA <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoCertificate under regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on March 31 2026 received from Kfin Technologies Limited Registrar and Transfer Agent of the Company.
4 months agoCertificate under regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on March 31 2026 received from Kfin Technologies Limited Registrar and Transfer Agent of the Company.
4 months agoThe trading window for dealing in securities of the Company shall be closed for all designated persons including Directors and promoters designated employees and their immediate relatives from April 01 2026 till completion of 48 hours after the declaration of Standalone audited financial results for half year and financial year ending on March 31 2026. Accordingly all designated persons designed employees and their immediate relatives are advised not to trade in the securities of the company during the aforesaid period of closure of trading window. This trading window closure notice operates independently and does not intend to amend alter modify curtail or extend any other notice on closure of trading window if any for any other purpose whether currently in effect or to be issued during the validity of this notice.
5 months agoThe trading window for dealing in securities of the Company shall be closed for all designated persons including Directors and promoters designated employees and their immediate relatives from April 01 2026 till completion of 48 hours after the declaration of Standalone audited financial results for half year and financial year ending on March 31 2026. Accordingly all designated persons designed employees and their immediate relatives are advised not to trade in the securities of the company during the aforesaid period of closure of trading window. This trading window closure notice operates independently and does not intend to amend alter modify curtail or extend any other notice on closure of trading window if any for any other purpose whether currently in effect or to be issued during the validity of this notice.
5 months agoCertificate under reg. 74(5) of SEBI (DP) Regulations 2018 for the Quarter Ended on December 31 2025.
5 months agoThe Company has approved the unaudited Standalone financial results for the half year ended on September 30 2025 along with the limited review report
9 months agoM/s. N R Shah & Co Company Secretaries Vadodara was appointed as Secretarial Auditor of the company for FY 2025-06 in pursuance of section 204 of the Companies Act 2013.
9 months agoM/s. R. M. Hariyani & Co Chartered Accounts Bharuch was appointed as internal auditor of the company for FY 2025-26.
9 months agoStatement of Deviation or Variation of funds raised through public issue for the period ended on September 30 2025
9 months agoUnaudited Standalone Financial Results for the half year ended on September 30 2025 along with Limited Review Report.
9 months agoThe Board of Directors of the Company at their meeting held today i.e. November 14 2025 inter alia duly approved and took on record the Unaudited Standalone Financial Results for the half year ended September 30 2025.Please find enclosed herewith the duly signed Unaudited Financial Results for the half year ended September 30 2025 along with the Limited Review Report. The same is also available on companys website i.e. www.maplehospital.in and on website of stock exchange www.bseindia.com. The Board also noted that there is no deviation(s) or variation(s) in respect of the utilization of the proceeds of initial public offering (IPO) of the company during the period from April 01 2025 to September 30 2025. Statement of deviation(s) and variation(s) of funds raised through IPO (equity shares) is annexed herewith. The Company also appointed Internal auditor and secretarial auditor for FY 2025-26
9 months agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve We wish to inform the Exchange that the meeting of the Board of Directors of BROACH LIFECARE HOSPITAL LIMITED (the Company) is scheduled to be held on Friday November 14 2025 at 04.00 p.m. at the registered office situated at 501 5TH FLOOR CORPORATE HOUSE ABOVE BHARUCH ORTHOPAEDIC HOSPITAL R K CASTA BHARUCH-392001 GUJARAT INDIA to inter alia transact following business:1. To consider and approve the unaudited financial results of the Company for the half year ended September 30 2025 2. Other Business as per Agenda of the Board meeting3. Any other business with permission of Chairperson
9 months agoCertificate of under reg 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on September 30 2025
10 months agoDeclaration of Voting Results of 2nd Annual General Meeting held on 30th September 2025 along with Scrutinizers Report.
11 months agoSummary of Proceedings of 2nd Annual General Meeting of the members of the Company held on Tuesday 30th September 2025 at 11.30 a.m. through VC/OAVM.
11 months agoThe trading window shall remain closed for all designated persons including directors and promoters designated employees and their immediate relatives from October 1 2025 till the completion of 48 hours after the declaration of standalone unaudited financial results of the company for the half year ended on September 30 2025
11 months agoThe Company has done news paper publication regarding notice of 2nd AGM intimation of cut off date and other details of evoting information.
12 months agoIntimation for letter being sent providing web link of 2nd Annual Report 2024- 25 and 2nd AGM notice to those members who have not registered their email address with the company or RTA or Depositories.
12 months ago2nd Annual Report for F.Y. 2024-25 along with Notice of 2nd Annual General Meeting of the Company
12 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
501, 5th Floor, Corporate House Above Bharuch Orthopaedic Hospital R K Casta Bharuch Gujarat PIN: 392001 Tel No: 9429187226 Fax No: NULL Email: [email protected] Internet: www.maplehospital.in
Registrars
301, 3rd Floor, The Centrium, : PHOENIX MARKETCITY, Kurla West, Kurla, Mumbai, Maharashtra, India 301, 3rd Floor, The Centrium Phoenix Marketcity Kurla West PIN: Tel No: NULL Fax No: NULL Email: NULL
Management
Dhyuti Krupesh Joshi, Chairperson
Jaykumar N Vyas, Managing Director
Shachi J Vyas, Whole Time Director
Mehul Narendrakumar Hingu, Non Executive Independent Director
Shrikrishna Ramesh Chaudhari, Non Executive Independent Director
Swati Sharma, Company Secretary & Compliance Officer
Details
BSE 544231
NSE NULL
ISIN INE0SFZ01018